Axim Biotechnologies, Inc. SEC filings AXIM
Axim Biotechnologies, Inc. has 306 filings in SEC EDGAR's recent list, going back to Mar 10, 2011. Its latest annual report, Form 10-K, was filed on Apr 16, 2024 for the period ended Dec 31, 2023. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2024, covering the quarter ended Jun 30, 2024. The most recent current report (Form 8-K) was filed on Oct 15, 2024 (change in control, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-1 | Registration statement | Jun 2, 2023 | — |
| S-1/A | Amended registration statement | Aug 2, 2022 | — |
| S-1 | Registration statement | Jul 25, 2022 | — |
| S-8 | Employee stock plan registration | Jun 14, 2022 | — |
| S-1/A | Amended registration statement | Jun 9, 2021 | — |
| S-1 | Registration statement | May 14, 2021 | — |
| 424B5 | Prospectus supplement | Dec 17, 2019 | — |
| 424B5 | Prospectus supplement | Apr 18, 2018 | — |
| S-3 | Shelf registration | Aug 24, 2017 | — |
| S-8 | Employee stock plan registration | May 29, 2015 | — |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AXIM (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1514946
- Former names
- AXIM INTERNATIONAL INC. (until Aug 13, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.